Trade

with

Biostar Pharmaceuticals Inc
(NASDAQ: BSPM)
AdChoices
1.50
+0.03
+2.15%
After Hours :
-
-
-

Open

1.53

Previous Close

1.47

Volume (Avg)

28.25k (202.62k)

Day's Range

1.46-1.53

52Wk Range

0.9500-3.49

Market Cap.

23.24M

Dividend Rate ( Yield )

-

Beta

2.71

Shares Outstanding

15.48M

P/E Ratio (EPS)

7.66 (0.20)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 52.73M

    • Net Income

    • 809.05k

    • Market Cap.

    • 23.24M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 5.02

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.71

    • Forward P/E

    • -

    • Price/Sales

    • 0.38

    • Price/Book Value

    • 0.34

    • Price/Cash flow

    • -94.34

      • EBITDA

      • 5.81M

      • Return on Capital %

      • 3.95

      • Return on Equity %

      • 4.59

      • Return on Assets %

      • 3.95

      • Book Value/Share

      • 4.35

      • Shares Outstanding

      • 15.48M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • 7.00

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 31.00

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -

          • 7.80

          • Net Income

            Q/Q (last year)

          • -

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 9.23

          • 6.10

          • Net Income

            5-Year Annual Average

          • -34.50

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 49.06

            • 69.92

            • Pre-Tax Margin

            • 6.71

            • 21.84

            • Net Profit Margin

            • 5.02

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 65.50

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 7.60

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 2.10

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.32

              • Current Ratio

              • 4.99

              • 1.92

              • Quick Ratio

              • 4.92

              • 1.31

              • Interest Coverage

              • 23.72

              • 17.64

              • Leverage Ratio

              • 1.15

              • 2.03

              • Book Value/Share

              • 4.35

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 7.76

                • 22.12

                • P/E Ratio 5-Year High

                • 84.37

                • 193.96

                • P/E Ratio 5-Year Low

                • 3.15

                • 87.26

                • Price/Sales Ratio

                • 0.39

                • 3.75

                • Price/Book Value

                • 0.35

                • 3.75

                • Price/Cash Flow Ratio

                • -94.34

                • 14.03

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 4.59

                    (9.60)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • 3.95

                    (8.40)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • 4.51

                    (9.70)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • 6.69k

                  • 90.07k

                  • Inventory Turnover

                  • 24.62

                  • 2.46

                  • Asset Turnover

                  • 0.79

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  508.22k
                  Operating Margin
                  0.96
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -94.34
                  Ownership

                  Institutional Ownership

                  4.99%

                  Top 10 Institutions

                  4.99%

                  Mutual Fund Ownership

                  -

                  Float

                  78.47%

                  5% / Insider Ownership

                  59.57%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Renaissance Technologies Corp

                  •  

                    563,670

                  • +4.18%

                  • 3.93

                  • Spark Investment Management LLC

                  •  

                    41,300

                  • -30.12%

                  • 0.28

                  • California Public Employees Retrmnt Sys

                  •  

                    14,118

                  • 0.00%

                  • 0.10

                  • Airain ltd

                  •  

                    12,010

                  • 0.00%

                  • 0.08

                  • Knight Capital Americas LLC

                  •  

                    10,977

                  • +2.07%

                  • 0.08

                  • Tower Research Capital LLC

                  •  

                    2,509

                  • -83.52%

                  • 0.02

                  • Merrill Lynch & Co Inc

                  •  

                    1,000

                  • 0.00%

                  • 0.01

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Slow Growth

                  Style

                  Small Value

                  Biostar Pharmaceuticals Inc is a Maryland corporation incorporated on March 27, 2007. It is a holding company that through its wholly-owned subsidiary Shaanxi Biostar Biotech, Ltd. and its variable interest entities Shaanxi Aoxing Ph...morearmaceutical Co., Ltd., and Shaanxi Weinan Aoxing Pharmaceuticals, LLC develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions in the Peoples Republic of China. Its popular product is Xin Ao Xing Oleanolic Acid Capsule, an over-the- counter (OTC) medicine for chronic hepatitis B. Its product line also includes five other OTC products, ten prescription-based pharmaceuticals, six nutriceuticals or health products and one medical device. The Company's products are derived from medicinal herbs that are either grown at its own facil...moreity or purchased from its suppliers. It has currently eight products under development to complement its existing product line. It has adopted international manufacturing standards and currently holds one patent, with two additional patents pending approval. The Company's products are currently being sold in over 25 provinces in the PRC through 25 distributors and an established network of more than 400 dedicated sales people. The Company's competitors includes, Wulanhaote Zhong Meng pharmaceutical Co., Ltd., Yang Ling Mai Di Sen Pharmaceutical Co., Ltd, Jiang Xi Ren He Pharmaceuticals, Inc; Hainan Asia Pharmaceuticals, Inc; Nan Yong An Pharmaceuticals, Inc; Hai Nan Min Hai Pharmaceuticals, Ltd; Shandong Bai Cao Pharmaceuticals, Ltd; Chang Chun Ren Min Pharmaceuticals, Ltd; Yun Nan Yu Xi City Wei He Pharmaceutical, Ltd; Shandong Phoenix Pharmaceuticals, Ltd; Wulanhaote Zhong Meng Pharmaceutical Co., Ltd; Yang Ling Mai Di Sen Pharmaceutical Co., Ltd; and other traditional Chinese medicine suppliers. The Company' operations and facilities are subject to environmental laws and regulations stipulated by the national and the local environment protection bureaus in the PRC.lessless

                  Key People

                  Mr. Ronghua Wang

                  CEO/Director/Chairman of the Board/President

                  Ms. Qinghua Liu

                  CFO/Chief Accounting Officer/Director

                  Mr. Haipeng Wu

                  Director

                  Mr. Zhongyang Shang

                  Director

                  Mr. King-fai Leung

                  Director

                  • Biostar Pharmaceuticals Inc

                  • No. 588 Shiji Xi Avenue

                  • Xianyang, Shaanxi Province 712046

                  • USA.Map

                  • Phone: +86 2933686638

                  • Fax: -

                  • biostarpharmaceuticals.com

                  Incorporated

                  2007

                  Employees

                  438

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: